-+ 0.00%
-+ 0.00%
-+ 0.00%

BeyondSpring's Subsidiary SEED Therapeutics Has Received FDA Orphan Drug Designation For ST-01156 For Treatment Of Neuroblastoma

Benzinga·08/13/2026 15:48:26
Listen to the news